Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system cells and inflammatory microenvironment represent a complex network of interactions between various leukocytes, stromal cells, and the extracellular matrix. These interactions are mediated by paracrine factors, such as cytokines and chemokines, and direct cell-cell contact via surface receptors. Paracrine signaling allows for rapid communication and recruitment of immune cells to sites of injury or malignancy (Grivennikov et al., Cell, 2010). Cell-cell contact, particularly through immune checkpoints like PD-1/PD-L1, provides critical regulatory signals that can either activate or exhaust immune responses (Binnewies et al., Nature Medicine, 2018). In oncology, this microenvironment is often hijacked to create an immunosuppressive niche that facilitates tumor growth and evasion of the immune system (Pitt et al., Annals of Oncology, 2016). In autoimmune and chronic inflammatory diseases, dysregulated signaling within this environment leads to persistent tissue damage. Therapeutic strategies aim to reprogram this environment by blocking inhibitory signals or neutralizing pro-inflammatory factors (Pardoll, Nature Reviews Cancer, 2012). While not a single molecular target, this system is the primary focus of modern immunotherapies and anti-inflammatory agents.
Modulation of the inflammatory milieu through inhibition of cytokines or checkpoint receptors to restore immune homeostasis or enhance anti-tumor activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system cells and inflammatory microenvironment via paracrine factors and cell–cell contact.